
ALEXANDRIA, Va., Jan. 15 (UPI) -- The U.S. military's Joint Program Executive Office for Chemical and Biological Defense has contracted the Tauri Group LLC for support services.
Under the three-year award, the analytical consulting firm will compete against five other awardees for task orders in the JPEO-CBD Medical Domain, which have a cumulative value of as much as $495 million.
Work would include provision of technical expertise in microbiology, molecular biology, chemistry, bio-surveillance and engineering. It would also include program management in support in Department of Defense acquisition and FDA regulations for medical counter-measure development.
"The Tauri team is prepared to hit the ground running to assist JPEO-CBD in developing and fielding medical counter-measures," said Ben Hagar, Tauri Group's program manager. "Our involvement with the Department of Defense's Transformational Medical Technologies program is longstanding, and we are excited about the opportunity to extend our support across the broader medical domain."
JPEO-CBD is responsible for research, development, acquisition, fielding, and life cycle support of chemical and biological defense equipment and medical counter-measures.
|
|
|
|
|
|
| Additional Security Industry Stories | |
NEW YORK, May 24 (UPI) --
Shale oil plays in the United States may be more attractive to investors than oil sands in Canada's Alberta province, a financial analyst said.
|
LEIDEN, Netherlands, May 24 (UPI) --
With South Korea edging closer to deciding on a contractor for its $7.3 billion KF-X fighter program a European competitor is dangling a new carrot to its bid.
|
Properties repossessed by lenders in the first quarter took an average of 477 days to complete the foreclosure process, up from 414 days in the previous...
|
Nobody likes spending cuts but the champion of that attitude is clearly President Barack Obama, who seems to have a very clear pain-avoidance agenda.
|
| Stories | Photos | Comments |
View Caption